Non-A, non-B hepatitis.
NANB hepatitis, almost certainly a syndrome due to several different viral agents, with different incubation periods and routes of transmission, has emerged as the predominant form of PTH and a major cause of chronic liver disease in developed countries. Pending isolation and characterization of the agents, much of our knowledge remains inferential, and basic virologic studies thus command the highest priority among investigations of this disease.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D003937:Diagnosis, Differential; D005260:Female; D006508:Hepatitis Antibodies / Q000032:analysis; D006512:Hepatitis B Core Antigens / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000276:immunology; D006526:Hepatitis C / Q000175:diagnosis* / Q000209:etiology / Q000276:immunology / Q000628:therapy; D006525:Hepatitis, Viral, Human / Q000175:diagnosis*; D006801:Humans; D008111:Liver Function Tests; D008297:Male; D006435:Renal Dialysis / Q000009:adverse effects; D065227:Transfusion Reaction
D006508:Hepatitis Antibodies; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens